Tuesday, 18 December 2018

China first to approve AstraZeneca, FibroGen anaemia drug

China has become the first country to approve a new anaemia drug from AstraZeneca and FibroGen, well before decisions by regulators in the United States or Europe.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)